当前位置: 首页 > 期刊 > 《中国医学创新》 > 2011年第24期
编号:13187293
肾康注射液对早期糖尿病肾病尿蛋白与血肌酐的影响
http://www.100md.com 2011年8月25日 王儒柏 王金翠 聂婷 陈兵
第1页

    参见附件。

     【摘要】 目的 探讨肾康注射液对糖尿病肾病尿蛋白与血肌酐降低的效果。方法 对100例患者随机分为治疗组60例,对照组40例,两组均给与常规治疗。治疗组加用肾康注射液治疗2个疗程(每个疗程3周,疗程间隔期6个月),治疗前后对照观察。结果 治疗组加用肾康注射液治疗2个疗程后,尿蛋白定量、血肌酐均较对照组有明显降低(P<0.05)。结论 肾康注射液对早期糖尿病肾病有明显疗效。

    【关键词】 肾康注射液; 糖尿病肾病; 尿蛋白; 血肌酐

    Shenkang injection of early diabetic nephropathy and serum creatinine of urine protein WANG Ru-bai,WANG Jin-cui,NIE Ting,et al.Shougang Steel Water Nephrology, General Hospital, Liupanshui 553028,China

    【Abstract】 Objective Probe into the effect of Shenkang Injection on lowering the urine protein and serum creatinine of diabetic nephropathy. Methods 100 patients were randomly allocated into two groups, where 60 patients in the treatment group and the other 40 patients in the control group. Except for the conventional treatment for both groups of patients, the patients in treatment group were additionally injected with the Shenkang Injection for two courses of treatment(3 weeks per course,and 6 months of interval between two courses).Then make a contrast observation ......

您现在查看是摘要介绍页,详见PDF附件